Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Population Pharmacokinetic-pharmacodynamic Study of Rituximab in Children With Blood Diseases

NCT05324917 is registered in ClinicalTrials.gov with The Affiliated Hospital of Qingdao University as lead sponsor.

NCT NCT05324917
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05324917 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Population Pharmacokinetic-pharmacodynamic Study of Rituximab in Children With Blood Diseases
Lead sponsor
The Affiliated Hospital of Qingdao University
Phase
Observational
Overall status
Unknown status
Start date
April 10, 2022
Completion date
April 1, 2023
Enrollment
20 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

blood disease, children, rituximab